Director/Moderator: Michele Sugrue, MS, MT(ASCP)SBB
Speaker: Duane Mitchell, M.D., Ph.D.; Joanne Kurtzberg, M.D.
Intended Audience: Physicians, Scientists, Technologists, Nurses
Teaching level: Intermediate
- Review historical background and laboratory approaches for cellular therapy in neurological diseases.
- Discuss the current status of cellular therapy and associated clinical trials neurological diseases.
- Describe innovative applications of immunotherapy to treat malignant brain tumors.
Event Description: Recent advances in cellular therapy have been found to be promising therapeutic options for the treatment of numerous neurologic diseases. Pre-clinical cellular therapy studies in neurodegenerative disorders such as Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis as well as neurovascular impairment conditions (i.e., stroke) have had encouraging results and are quickly moving into clinical trials. In addition, harnessing the potential of cellular immunotherapy, studies have demonstrated that one may drive the immune system to attack neuro-derived brain cancer cells. In this program, speakers will review the strategies and methodologies for these innovative approaches. The status of translational investigations and current clinical trials will be discussed. In addition, future modalities and approaches to developing curative therapies will be addressed.
Location: OCCC - W224 G/H